ClinicalTrials.Veeva

Menu
T

Tohoku Medical and Pharmaceutical University Hospital | Center for Clinical Research Promotion and Development

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Clarithromycin
Androgen
Lumicitabine
Abiraterone
Felzartamab
Docetaxel
Bedaquiline
Ustekinumab
Enzalutamide
Molidustat

Parent organization

This site is a part of Tohoku Medical and Pharmaceutical University Hospital

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 15 total trials

A Study of E6742 in Participants With Systemic Lupus Erythematosus

The main purpose of the study is to demonstrate the efficacy based on dose response of E6742 compared with placebo as defined by the proportion of pa...

Not yet enrolling
Systemic Lupus Erythematosus
Other: Placebo
Drug: E6742

The main aim of the study is to check for side effects from TAK-771, and to check how well TAK-771 controls symptoms in Japanese participants with ch...

Active, not recruiting
Multifocal Motor Neuropathy (MMN)
Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Drug: TAK-771

Psoriatic arthritis (PsA) is a chronic inflammatory disease that affects the joints and skin in people who have psoriasis (PsO).The main aim of the s...

Enrolling
Psoriatic Arthritis
Drug: Placebo
Drug: Zasocitinib

In this study, researchers will learn more about the use of felzartamab in participants with immunoglobulin A nephropathy (IgAN). This study will foc...

Enrolling
Immunoglobulin A Nephropathy (IgAN)
Drug: Felzartamab
Drug: Placebo

Trial sponsors

Chugai Pharmaceutical logo
Janssen (J&J Innovative Medicine) logo
Bayer logo
Biogen logo
Takeda logo
Eisai logo
Janssen (J&J Innovative Medicine) logo
N

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems